Previous Close | 3.52 |
1-Year Change | -62.43% |
6-Months Change | -45.76% |
3-Months Change | -24.95% |
Moving Avg (50d) | 4.253 |
Moving Avg (200d) | 6.7944 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.55B |
Beta (3-Years) | 0.53 |
Revenue Growth (ttm) | 2.82% |
Net Profit Margin (ttm) | -220.24% |
Return On Assets (ttm) | -181.71% |
EPS (ttm) | -6.23 |
PE Ratio (ttm) | -0.57 |
Dividend Yield | % |
Asset Description: | Ironwood Pharmaceuticals, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-27 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
3.548 | 3.439 | 3.367 | 3.258 | 3.077 | 2.896 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |